Resmed Inc
NYSE:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
NYSE:RMD
Watchlist
Price: 246.23 USD 1.08%
Market Cap: 36.1B USD
Have any thoughts about
Resmed Inc?
Write Note

Resmed Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Resmed Inc
Cash Equivalents Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Resmed Inc
NYSE:RMD
Cash Equivalents
$426.4m
CAGR 3-Years
16%
CAGR 5-Years
20%
CAGR 10-Years
-7%
Becton Dickinson and Co
NYSE:BDX
Cash Equivalents
$4.5B
CAGR 3-Years
12%
CAGR 5-Years
54%
CAGR 10-Years
10%
Boston Scientific Corp
NYSE:BSX
Cash Equivalents
$2.5B
CAGR 3-Years
9%
CAGR 5-Years
55%
CAGR 10-Years
26%
Stryker Corp
NYSE:SYK
Cash Equivalents
$3.9B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
11%
Abbott Laboratories
NYSE:ABT
Cash Equivalents
$7B
CAGR 3-Years
-9%
CAGR 5-Years
11%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash Equivalents
$1.8B
CAGR 3-Years
32%
CAGR 5-Years
23%
CAGR 10-Years
14%

See Also

What is Resmed Inc's Cash Equivalents?
Cash Equivalents
426.4m USD

Based on the financial report for Sep 30, 2024, Resmed Inc's Cash Equivalents amounts to 426.4m USD.

What is Resmed Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
-7%

Over the last year, the Cash Equivalents growth was 104%. The average annual Cash Equivalents growth rates for Resmed Inc have been 16% over the past three years , 20% over the past five years , and -7% over the past ten years .

Back to Top